ELEV
Income statement / Annual
Last year (2024), Elevation Oncology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Elevation Oncology, Inc.'s net income was -$44.49 M.
See Elevation Oncology, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$39,000.00
|
$27,000.00
|
$18,000.00
|
$15,000.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$39,000.00
|
-$27,000.00
|
-$18,000.00
|
-$15,000.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$28.60 M
|
$25.43 M
|
$78.72 M
|
$23.60 M
|
$15.48 M
|
$5.34 M
|
| General & Administrative Expenses |
$16.11 M
|
$14.90 M
|
$15.83 M
|
$8.45 M
|
$1.80 M
|
$816,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$543,184.00
|
| Selling, General & Administrative Expenses |
$16.11 M
|
$14.90 M
|
$15.83 M
|
$8.45 M
|
$1.80 M
|
$544,000.00
|
| Other Expenses |
$0.00
|
$5.11 M
|
-$506,000.00
|
$7,000.00
|
$11,000.00
|
$0.00
|
| Operating Expenses |
$44.70 M
|
$45.45 M
|
$94.55 M
|
$32.05 M
|
$17.28 M
|
$5.88 M
|
| Cost And Expenses |
$0.00
|
$45.45 M
|
$94.55 M
|
$32.05 M
|
$17.28 M
|
$5.88 M
|
| Interest Income |
$0.00
|
$3.90 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.20 M
|
$4.17 M
|
$479,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$39,000.00
|
$27,000.00
|
$18,000.00
|
$15,000.00
|
$3.57 M
|
| EBITDA |
-$44.70 M |
-$41.47 M |
-$94.52 M |
-$32.03 M |
-$17.25 M |
-$5.88 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$261,000.00
|
-$229,000.00
|
-$506,000.00
|
$7,000.00
|
$11,000.00
|
$0.00
|
| Income Before Tax |
-$44.44 M
|
-$45.67 M
|
-$95.06 M
|
-$32.04 M
|
-$17.27 M
|
-$5.88 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$43,000.00
|
$30,000.00
|
$25,000.00
|
-$218,558.00
|
-$191,297.00
|
-$8,823.00
|
| Net Income |
-$44.49 M
|
-$45.70 M
|
-$95.08 M
|
-$32.04 M
|
-$17.27 M
|
-$5.88 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.78 |
-1.34 |
-4.09 |
-1.38 |
-0.73 |
-0.25 |
| EPS Diluted |
-0.78 |
-1.34 |
-4.09 |
-1.38 |
-0.73 |
-0.25 |
| Weighted Average Shares Out |
$57.28 M
|
$34.08 M
|
$23.27 M
|
$23.21 M
|
$23.76 M
|
$23.76 M
|
| Weighted Average Shares Out Diluted |
$57.28 M
|
$34.08 M
|
$23.27 M
|
$23.21 M
|
$23.76 M
|
$23.76 M
|
| Link |
|
|
|
|
|
|
